IFAAS Mini-Fellowship (Observation)

Injectable Tissue Replacement and Regeneration & ABC Face Lift

 

Date:

February 20-21, 2020

 

Faculty:

Steve Cohen, M.D., United States 

Venue: 

San Diego, CA, United States 

 Registration: 

3,000 USD 

 

*IFAAS Members collect 5% Credit Rebate to be utilized for all future IFAAS events

 

 

(Maximum 12 Attendees) -

IFAAS Certificate will be issued upon completion of the Fellowship

Learning Objectives: 

  • Learn how to diagnose specific anatomic locations of facial volume loss by evaluating the surface topography of the face 

  • Learn how to replace these anatomic losses in the fat and bone with autogenous or allogenic fat graphs that are different anatomic shapes, including Pyriform Aperture Injection, Liquid Columellar Struts, Glabellar/Forehead Augmentation/Hand Rejuvenation 

  • Learn Dr Cohen’s ITR2 technique, which standardises the facial fat grafting process to create consistently beautiful and effective results with each procedure in 3 different sizes 

  • Learn about current treatments in regenerative medicine including Nanofat, SVF and PRP 

  • Learn how to do injectable tissue replacement in combination with different types of facelifts, including SMAS, SMASectomy, SMAS plication and modified MACS lift 

 

Course Overview: 

This mini fellowship will teach you how to properly harvest, process, and deliver fat and nanofat, as well as combining it with different types of facelifts, including SMAS, SMASectomy, SMAS plication and modified MACS lift. 

 

The delegate will learn how to analyze a face and determine the anatomic areas of fat loss, bone loss and skin thinning. In addition, multiple modalities to address the 3 major features of aging will be demonstrated so simultaneous treatment of sun damage, volume loss and laxity can be performed in order to achieve the best outcomes that a patient now expects. 

 

Aging is a dynamic process that can be modeled and understood tissue by tissue and cell by cell. Numerous authors have helped us understand the anatomy of facial fat compartments and the effects of aging on our facial tissues such as skin, fat, bone and fibrous ligaments.

 

Injectable Tissue Replacement and Regeneration (ITR2) is a method to replace decayed tissues of the face using “like tissues” in an effort to delay or slow the rate of tissue decay seen in facial aging. Facial topography and proportion analysis are performed to diagnose individual-specific losses of facial fat. The degree of sun damage and skin thinning is noted as is the degree of loss in the superficial fat compartment. Deep compartment fat loss is evaluated as is pyriform aperture, mandibular ramus, mandibular body and chin resorption. From this analysis, a detailed treatment plan is formulated.

 

Using either a sizing device that creates 3 different fat grafts; 2 mm (millifat), 1 mm (microfat) and 800 microns or less parcel size (nanofat); anatomic replacement of all areas of tissue loss is carried out.44 Millifat is used for deep compartment and bone losses, microfat for superficial fat losses above the facial musculature and nanofat is used intradermally and as a biological cream for topical application. The rationale behind this standardized approach is explained and the scientific foundations for the idea are presented.

 

Dr Cohen will also cover the topics on a new facelift technique co-invented by Dr Michael Atlan, Dr Patrick Barat and himself, called the ABC Facelift, includes 3 steps of A. Dr Cohen’s ITR2 Fat Grafting Technique; B. Dr. Baraf’s Non-incisional Skin Elevation and C. Dr Baraf and Dr Cohen’s Cautery Elevation of the SMAS. 

 

Program: 

 

 

Day 1: Thursday, February 20, 2020

 

07:30 - 08:00 Registration  

 

08:00 - 10:00 Lecture on Injectable Tissue Replacement and Regeneration & ABC Face Lift

 

10:00 - 17:00  Full Day Observation in the Operation Room Injectable Tissue Replacement and Regeneration & ABC Face Lift

 

 

 

Day 2: Friday, February 21, 2020

 

08:30 - 09:00 Registration  

 

09:00 - 17:00  Full Day Observation in the Operation Room Injectable Tissue Replacement and Regeneration & ABC Face Lift

 

Faculty: 

Steve Cohen, M.D., United States

Dr. Cohen has written over 150 articles for the medical literature and serves on the editorial board of Aesthetic Plastic Surgery and the Aesthetic Surgery Journal. For 9 of the past 12 years, Dr. Cohen has been named by his peers as one of the Best Plastic Surgeons as reported in San Diego Magazine. In 2016, the SD Metro Magazine named Dr. Cohen one of the Best Doctors in San Diego.  He was cited in 2001-2016 as one of the nation’s Top Doctors by Best Doctors, Inc. and in 2004-2016 by Castle Connolly as one of the Top Doctors in America. In 2011 he was selected as one of the top plastic surgeons in the U.S. by the U.S. News and World Report. 

Dr. Cohen is known throughout the world for his contributions in the treatment of children with facial deformities and his work in helping to pioneer new regenerative cell therapies in both his own specialty as well as in Orthopedic Surgery, Sports Medicine & Cardiology. He is the inventor of the first commercially distributed internal distraction system, the MID system (Stryker, Inc.), and holds a patent on the Macropore biodegradable distraction device. Dr. Cohen recently has co-invented a new outpatient Biofilling kit with Tulip Medical and closed system liposuction and automatic fat grafting device with Millenium Medical Technologies. Dr. Cohen was first in the world to treat infants with Pierre Robin with distraction and this has become the procedure of choice to prevent the need for tracheostomy in these little children. Along with Dr. Meltzer, their Craniofacial team at Rady Children’s Hospital was the second group in the world to perform endoscopic craniosynostosis surgery, which has become an important option of care in patients with sagittal synostosis. He was formerly on the executive boards of the American Society of Craniofacial Surgery, the American Society of Maxillofacial Surgeons and the American Cleft Palate-Craniofacial Association. Dr. Cohen was a founder of the Cell Society, an international organization dedicated to educating physicians and the public on emerging treatments in Regenerative Medicine.

Please reload

©2014-2019 by IFAAS. Powered by: SurgeMed, a leading Medical Education, Marketing & Operation Agency.